Guided Therapeutics (GTHP) Total Liabilities (2010 - 2025)

Guided Therapeutics (GTHP) has 16 years of Total Liabilities data on file, last reported at $7.3 million in Q4 2025.

• For the quarter ending Q4 2025, Total Liabilities rose 16.96% year-over-year to $7.3 million; the trailing twelve-month figure through Dec 2025 stood at $7.3 million (up 16.96% YoY), and the FY2025 full-year result was $7.3 million, up 16.96% from the prior year.
• Total Liabilities improved to $7.3 million in Q4 2025, from $6.5 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $10.3 million in Q1 2021 to a low of $5.5 million in Q4 2023.
• A 5-year average of $6.6 million and a median of $6.3 million in 2024 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities tumbled 57.44% in 2021 and grew 16.96% in 2025, its largest moves.
• Tracing GTHP's Total Liabilities over 5 years: stood at $7.5 million in 2021, then declined by 16.51% to $6.2 million in 2022, then dropped by 12.39% to $5.5 million in 2023, then rose by 14.47% to $6.3 million in 2024, then grew by 16.96% to $7.3 million in 2025.
• Business Quant data shows GTHP's Total Liabilities at $7.3 million in Q4 2025, $6.5 million in Q3 2025, and $6.4 million in Q2 2025.